Chen-Wei Ho

Dr. Chen-Wei Ho


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
CHChen-Wei Ho
Chen-Wei Ho
YWYu-Lun Wu
Yu-Lun Wu
YCYi-Chun Chen
Yi-Chun Chen
YJYuJeng Ju
YuJeng Ju
MWMing-Ting Wu
Ming-Ting Wu
Objectives: We aimed to investigate whether AI assistance could improve the performance of pneumothorax detection on chest radiographs (CXR) by readers with varying experience from radiologists to the frontline healthcare providers, and whether AI assistance could diminish the potential confounders for readers’ detecting pneumothorax. Methods: In this retrospective, single-center, blinded, multi-reader diagnostic accuracy study, 125 CXRs were prepared from radiological information system (March 2024 to August 2024) for test. The 18 readers were composed of six groups, each had 3 persons: board-certified radiologists (Group-1), senior radiology residents (Group-2), junior radiology residents (Group-3), postgraduate year residents (Group-4), senior radiographers (Group-5), and junior radiographers (Group-6). They read the CXR independently twice, without and with AI assistance, at an interval of one month. We used receiver operating characteristic curve for performance analysis and generalized estimating equation (GEE) model for confounding factor analysis. Results: AI software alone achieved a high area under curve of 0.965 (95% CI: 0.926, 0.995). With AI assistance, the performance in all groups significantly improved (p < 0.01) especially the junior readers (the frontline healthcare providers, Group-3, 4, 6) and diminished the difference among all groups except some related to Group-1. GEE model showed that AI assistance, reader’s experience, and projection type interfere with the readers’ performance (all p < 0.05). Conclusions: AI assistance could improve the performance of pneumothorax detection by varying experience of readers, especially the frontline healthcare providers. The influence of confounders, such as reader’s experience, also be diminished by AI assistance.

20 August 2026 in The Kaohsiung Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
YWYu‐Lun Wu
Yu‐Lun Wu
CHChen-Wei Ho
Chen-Wei Ho
WLWen‐Shiung Liou
Wen‐Shiung Liou
CYChun‐Hao Yin
Chun‐Hao Yin
JCJin‐Shuen Chen
Jin‐Shuen Chen
JCJu‐Chun Chien
Ju‐Chun Chien
For cervical cancer, the choice between definitive radiotherapy (RT) and surgery has long been a topic of debate. Clinical factors, including histology and tumor burden, have been examined in prior studies. Given recent advances in RT and the incorporation of concurrent chemotherapy, our study seeks to assess the optimal treatment modality for cervical cancer in current clinical practice. The cancer registry database of a medical center was screened for cervical cancer patients. Patients receiving curative intent RT or surgery were included. Clinicopathological factors and treatment outcomes were retrospectively collected. The disease‐free survival (DFS) and overall survival (OS) were analyzed using Cox regression and Kaplan–Meier analyses. From 2007 to 2021, 369 squamous cell carcinoma (SCC) and 108 adenocarcinoma (AC) cases were enrolled. AC had an increasing proportion over time and was associated with worse survival. Comparing RT to surgery, RT was associated with inferior survival in both early‐stage AC (DFS, HR: 8.29, p < 0.001, 95% CI: 3.21–21.42) and SCC group (DFS, HR: 4.01, p < 0.001, 95% CI: 1.99–8.08). The difference was more robust in those with tumors smaller than 4 cm. For advanced‐stage disease, the inferiority of RT was observed in the SCC (DFS, HR: 1.85, p = 0.020, 95% CI: 1.10–3.11), but not AC group. There was no statistically significant intergroup difference observed between the AC and SCC groups regarding DFS of RT versus surgery. In our analysis, AC was an independent poor prognostic factor. Despite the addition of concurrent chemotherapy and advanced RT techniques, surgery‐based treatment was still associated with superior survival for early‐stage cervical cancer.